Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.
暂无分享，去创建一个
S. Park | A. Navarro | M. Schuler | B. Cho | M. Ocker | H. Richly | M. Joerger | S. Bender | R. Cathomas | R. Soo | P. Rajagopalan | M. Schostak | N. Penel | P. Cassier | L. Nogova | J. Grevel | O. Boix | P. Ellinghaus | H. Nogai | P. Gajate | D. Tai | C. Sayehli